Previous 10 | Next 10 |
2023-10-03 07:00:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As economic and stock market uncertainty looms, you may think at first that now is not a great time to be dabbling in speculative stocks. Yet, while the broad market may be experiencing tur...
SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that company management will participate in a fireside chat and 1x1 investor meetings at the Cantor Global Healthcare Conference, which is being held in New York City on September 26-2...
2023-09-19 09:11:54 ET From Sept. 10 to Sept. 15, Crinetics Pharmaceuticals (NASDAQ: CRNX) stock price gained 83%, and it's still climbing rapidly. The pre-revenue biotech's lead candidate, called paltusotine, reported some great phase 3 results, suggesting that the once-daily oral ...
2023-09-18 12:15:50 ET Summary San Diego-based biotech Crinetics Pharmaceuticals saw its share price soar by 75% after positive results from its Phase 3 study of paltusotine, an oral treatment for acromegaly. The study met its primary endpoint and all secondary endpoints, with 83%...
2023-09-15 08:37:48 ET Shares of the rare disease specialist Crinetics Pharmaceuticals (NASDAQ: CRNX) have been on fire this week. Through the first four days of trading, the biotech's stock has already gained a healthy 81.3%, according to data provided by S&P Global Market In...
2023-09-13 06:45:06 ET More on Crinetics Pharmaceuticals Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals Crinetics Pharmaceuticals: Creating Next-Generation Treatments In Acromegaly Crinetics Pharmaceuticals: Paltusotine Phase 3 Data Presented At END...
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, announced today the pricing ...
2023-09-11 16:12:13 ET More on Crinetics Pharmaceuticals Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals Historical earnings data for Crinetics Pharmaceuticals Financial information for Crinetics Pharmaceuticals Crinetics Pharmaceuticals: Cre...
2023-09-11 12:58:57 ET Gainers: Super League Gaming ( SLE ) +182% . Crinetics Pharmaceuticals ( CRNX ) +66% . Aurora Cannabis ( ACB ) +55% . Canopy Growth Corporation ( CGC ) +46% . Avantax ( AVTA ) +28% . Clever Leaves Holdi...
2023-09-11 12:57:53 ET Shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) were up more than 67% as of 12:30 p.m. ET on Monday after the company posted positive phase 3 trial results for one of its therapies. The healthcare stock is up more than 28% for the year. Crinetics fo...
News, Short Squeeze, Breakout and More Instantly...
Crinetics Pharmaceuticals Inc. Company Name:
CRNX Stock Symbol:
NASDAQ Market:
Crinetics Pharmaceuticals Inc. Website:
2024-06-25 22:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, was named an Entrepreneur Of The Year ® 2024 Pacific Southwest Award winner. Entrepreneur Of The Year is the preeminen...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its com...